Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
The latest announcement is out from Rayonier Advanced Materials ( (RYAM) ).
Rayonier Advanced Materials reported its third-quarter 2025 financial results, highlighting a net sales decrease to $353 million and a loss from continuing operations of $4 million, which is an improvement from the previous year. Despite a decrease in adjusted EBITDA, the company expects improved financial performance in the fourth quarter, with a long-term strategy to achieve over $300 million in run-rate EBITDA by 2027. The results reflect the company’s resilience and stabilization in demand and operational performance.
The most recent analyst rating on (RYAM) stock is a Hold with a $9.00 price target. To see the full list of analyst forecasts on Rayonier Advanced Materials stock, see the RYAM Stock Forecast page.
Spark’s Take on RYAM Stock
According to Spark, TipRanks’ AI Analyst, RYAM is a Neutral.
Rayonier Advanced Materials’ overall stock score is primarily impacted by its weak financial performance and bearish technical indicators. The company’s profitability challenges and negative valuation metrics weigh heavily on the score. While there are some positive strategic initiatives and cost reduction efforts, these are not enough to offset the current financial and market challenges.
To see Spark’s full report on RYAM stock, click here.
More about Rayonier Advanced Materials
Rayonier Advanced Materials Inc. operates in the cellulose specialties industry, focusing on the production of high-purity cellulose products used in a variety of applications such as textiles, pharmaceuticals, and food. The company is listed on the New York Stock Exchange under the symbol RYAM.
Average Trading Volume: 724,759
Technical Sentiment Signal: Hold
Current Market Cap: $437.5M
Find detailed analytics on RYAM stock on TipRanks’ Stock Analysis page.

